IP Library Granted Patent US 11,839,690
Granted Patent B2
US 11,839,690 · App. 17/644,296 · Granted Dec 12, 2023

Wound dressing layer for improved fluid removal

Inventors: Christopher Brian Locke (Bournemouth, GB); Timothy Mark Robinson (Shillingstone, GB)
Assignee: KCI Licensing, Inc.
A61L15/425A61F13/00068A61L15/26
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,839,690
App. No.
17/644,296
Granted
Dec 12, 2023
Kind
B2
Abstract

Disclosed herein are embodiments of a wound dressing layer. The wound dressing layer may include an open-cell foam. The foam may have a 50% compression force deflection of not more than about 4.8 kPa. The foam may also have a density of at least 24 kg/m 3 . The foam may exhibit a density increase of a factor of at least 12 at about −75 mmHg.

Claims (18)

1. A negative-pressure wound therapy system, comprising:

a wound dressing, the wound dressing comprising an open-cell foam having a 50% compression force deflection of not more than about 4.8 kPa, a density of at least 24 kg/m, and exhibiting a density increase of a factor of at least 12 at about −75 mmHg;

wherein the wound dressing is configured to be disposed under a cover, the cover configured to be attached to tissue surrounding a tissue site; and

wherein the wound dressing is configured to be fluidly coupled to a negative-pressure source.

2. The negative-pressure wound therapy system of claim 1 , wherein the 50% compression force deflection is not more than about 4.5 kPa.

3. The negative-pressure wound therapy system of claim 1 , wherein the 50% compression force deflection is not more than about 4.0 kPa.

4. The negative-pressure wound therapy system of claim 1 , wherein the 50% compression force deflection the not more than about 3.5 kPa.

5. The negative-pressure wound therapy system of claim 1 , wherein the 50% compression force deflection not more than about 3.0 kPa.

6. The negative-pressure wound therapy system of claim 1 , wherein the density is at least 28 kg/m′.

7. The negative-pressure wound therapy system of claim 1 , wherein the density is at least 32 kg/m′.

8. The negative-pressure wound therapy system of claim 1 , wherein the density is at least 36 kg/m′.

9. The negative-pressure wound therapy system of claim 1 , wherein the density is at least 40 kg/m′.

10. The negative-pressure wound therapy system of claim 1 , wherein the density increase is a factor of at least 5 at about −25 mmHg.

11. The negative-pressure wound therapy system of claim 1 , wherein the density increase is a factor is at least 9 at about −50 mmHg.

12. The negative-pressure wound therapy system of claim 1 , wherein the density increase of a factor is at least 14 at about −100 mmHg.

13. The negative-pressure wound therapy system of claim 1 , wherein the density increase is a factor of at least 16 at about −125 mmHg.

14. The negative-pressure wound therapy system of claim 1 , wherein the wound dressing is hydrophobic.

15. The negative-pressure wound therapy system of claim 1 , wherein the open-cell foam is formed from polyurethane.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2024
From: 3M INNOVATIVE PROPERTIES COMPANY
To: SOLVENTUM INTELLECTUAL PROPERTIES COMPANY
Reel/Frame 066444/0162 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 28, 2023
From: KCI LICENSING, INC.
To: 3M INNOVATIVE PROPERTIES COMPANY
Reel/Frame 064730/0636 →